We’re celebrating our 2nd year anniversary!!! Throw back to our first ORG research meeting over beers and King burritos 5/25/2019!! 🥳

In a real-world setting, patients with metastatic ccRCC who received first-line immunotherapy or combination immuno/targeted therapy had improved OS compared to those who received first-line targeted therapy alone.

January 2021 Issue Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors https://t.co/g7sDrR2jN3

#SUO20 #Debate: Neoadjuvant vs. Adjuvant Chemotherapy for #UTUC. Neoadjuvant presentation by Jen-Jane Liu, MD @OHSUurology. Written coverage by @GoldbergHanan @UrologyUpstate on UroToday > https://t.co/JCkSVCanEZ @UroOnc @SUO_YUO

Excellent debate led by @siadaneshmand b/w neaodjuvant vs adjuvant chemo for #utuc by @JJLiuMD & our very own @UNCUroOnc super ⭐️ @TracyLRoseMD Like bladder, will be about selecting who benefits most from NAC, avoiding overttreatment #suo20

Proud of our superstar fellow Dr Nick Chakiryan and his presented podium at virtual SUO 2020. Highly actionable results ie primary tumor stage drives nodal upstaging. @MoffittGUOnc @AndreaNecchi @SpiessPhilippe @SUO_YUO

Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 #Penile squamous cell carcinoma. Presented by Nicholas Chakiryan, MD @MoffittNews. #SUO20 written coverage by @zklaassen_md @GACancerCenter > https://t.co/1fFZvSwNMV @UroOnc @SUO_YUO

We wish our applicants could be here in person to interview on this beautiful Portland day! Looking forward to meeting you all today!

Urology residents! Please join us this week for our Moffitt Cancer Center meet & greet at the SUO virtual meeting. Register at either time slot below. Looking forward to meeting you! @SUO_YUO https://t.co/xbTxXUKVqU https://t.co/MQeVIVsknx

Can’t forget @MitchHayesMD

Misaligned Incentives in Benign Prostatic Enlargement Surgery: More Complex and Efficacious Procedures are Earning Less @DavidJiangMD @KyleGillis5 @rkorets @DrewWagnermd @JCHedgesMDPhD @OHSUurology @BIDMCUrology

You are never too big to make someone's day with a little gesture... Hope this brings a smile...

Platinum Priority Editorial from @AydinAMurat Nicholas H. Chakiryan @SpiessPhilippe Will Dynamic Sentinel Lymph Node Biopsy Become the New International Standard for Evaluating High-risk Penile Cancer in Patients with Clinically Negative Lymph Nodes? https://t.co/vmXfax6r0d

This study took me two years. Blood. Sweat. Mockery. But got it done Your MIS patients do not need opioids. You can convince your colleagues to stop as well using behavioral interventions. MOST important! Patient-Reported-Outcomes EXACTLY the same https://t.co/91HU73Bzpk

Legend of urology. He will be sadly missed.

When Trump glorifies one, we inevitably get the other. If you don’t see how uplifting the McCloskeys emboldens people like Kyle Rittenhouse then you’re not paying attention.

Nice to see our methodology used in other specialties!! ⭐️ENT no correlation between operative time RVU/hr. @Rutgers_NJMS Time is Money: Relative Value Units and Operative Time in Otolaryngology

Everyone depends on the USPS. Seniors for their Social Security, veterans for their prescriptions, small businesses trying to keep their doors open. They can't be collateral damage for an administration more concerned with suppressing the vote than suppressing a virus.

Celebrating another successful publication with @DavidJiangMD @OBrienRsrchGrp @KyleGillis5. wRVUs do not adequately account for OR time in pediatric urology 👇 https://t.co/CLtI0H1aXN

It's always a pleasure working with the formidable Dr. @rx_haslam. Strong work on this paper, and many more to come ⚡️ Educational value of YouTube surgical videos of pediatric robotic-assisted laparoscopic pyeloplasty https://t.co/oeU0LyNYdo